Reporting of adverse drug reactions to be compulsory at pharmacy

Published: 2004-04-30 06:56:00

Updated: 2004-04-30 06:56:00

The Korea Food and Drug Administration announced it has revised the rules on safety information of drugs, etc. after screening from the National Reform Committee, saying that its revised rules are designed to enhance the efficiency and transparency of Korea's ADR (adverse drug reaction) monitorin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK